Login / Signup

Naevus lightening in melanoma patients under BRAF/MEK inhibitor combination therapy versus checkpoint immunotherapy: A histological and immunohistochemistry analysis.

Cathy Yunjia ZhaoShaun ChouRose Congwei LiuPablo Fernandez-Peñas
Published in: Pigment cell & melanoma research (2017)
Keyphrases
  • combination therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • metastatic colorectal cancer
  • wild type
  • basal cell carcinoma